Objectives: Recently, diffusion-weighted MR imaging (DWI) for the whole body has become available for clinical use, as has been previously used for the central nervous system. Favorable results have been reported using this imaging system to differentiate between benign and malignant lesions in some organs, and to correlate with the degree of cell differentiation in lung cancer. The purpose of this study was to assess the role of DWI for predicting tumor invasiveness of non-small cell lung cancers (NSCLC), especially for clinical stage IA patients. Methods: From January 2006 to September 2007, preoperative DWI and 18F-FDG-PET/CT were performed on 41 patients with clinical stage IA NSCLC who had undergone curative operations. Lung cancers that exhibited nodal, lymphovascular or pleural invasion were defined as invasive lung cancers. Nodules with strong dark signal, as observed by DWI in spinal cords, were defined as DWI-positive. We analyzed the associations between the pathological findings and the following preoperative clinical factors: age, gender, smoking history, preoperative CEA levels (<5.0 or !5.0 ng/ml), preoperative tumor size, SUV max on PET/CT (<5.0 or !5.0) and DWI (positive or negative). Results: A total of 15 lesions (37%) were assessed as DWI-positive and 26 lesions (63%) were DWI-negative. Univariate analyses showed positive correlations for development of invasive cancer with the preoperative CEA level ( p = 0.049), SUV max ( p = 0.001) and DWI ( p < 0.001). Multivariate analysis showed that DWI ( p = 0.005) was an independent predictive factor for tumor invasiveness. Conclusion: Our results suggest that DWI might be a useful method for predicting tumor invasiveness for clinical stage IA NSCLC. #
Introduction
In recent years, the number of patients diagnosed with small lung cancer has increased as a result of improved diagnostic imaging technologies. As a result, cases are also increasing for which limited surgery leads to a complete cure [1] . However, primary lung cancer is still one of the cancers with the poorest prognosis, with lymph node metastases observed in approximately 20% of non-small cell lung cancer (NSCLC) patients, even in clinical stage IA [2] . A certain proportion of clinical stage IA NSCLC patients are thus expected to develop invasive cancer [3] [4] [5] [6] . Accordingly, in order to make a determination for a limited operation, it is important to adequately assess possible tumor invasiveness before the operation.
Recently, diffusion-weighted MR imaging (DWI) for the whole body has become available for clinical use [7] [8] [9] , as has been previously used for the central nervous system [10, 11] .
Favorable results have been reported by several authors using this imaging system to differentiate between benign and malignant lesions in some organs [12, 13] , and to correlate with the degree of cell differentiation in lung cancer [14] .
DWI targets and visualizes the diffusion status of water molecules within tissues. Because water molecules exist chiefly in the extracellular fluid, diffusion will be inhibited depending upon cellular density and cell size [8, [14] [15] [16] . Because a higher cellular density indicates a highly malignant lesion, DWI might be expected to improve the prediction of tumor invasiveness.
In this study, we examined the possibility of predicting tumor invasiveness by qualitative DWI evaluation in patients with clinical stage IA NSCLC.
Materials and methods

Patients
We included 41 patients who underwent integrated positron emission tomography-computed tomography with F-18 fluorodeoxyglucose (FDG-PET/CT) and DWI before their operations from among 60 patients with NSCLC in clinical stage IA who had curative operations between January 2006 and September 2007 at Yamagata University Hospital. We excluded patients who had partial resections because evaluations for lymph node metastases were insufficient, who had not undergone either FDG-PET/CT or DWI, and who had multiple primary lung cancers. This study was performed with the approval of the hospital ethics committee of the Yamagata University School of Medicine.
Clinical staging
Thoracic plain X-ray and thoracoabdominal CT were performed within 1 month before the operation. The sizes of tumors were evaluated with thin-section CT and lymph node metastases were evaluated with conventional CT. Patients with enlarged lymph nodes, having minimum diameter >1 cm, were considered to have lymph node metastasis. None of the patients received a mediastinoscopy. Bone metastasis was evaluated by bone scintigraphy, and brain metastasis by brain CT or MRI as needed.
MRI diffusion-weighted imaging
DWI was performed with breath-holding using an Achiva 1.5-T (Philips, Netherlands) within 1 month before the operation. Parameters were set as shown in Table 1 : b value was set at 1000 s/mm 3 . The images were assessed on black and white reversed-contrast film. Nodules with strong dark signal, as observed by DWI in spinal cords, were defined as DWI-positive (Fig. 1a) . Otherwise, they were considered DWInegative (Fig. 1b) .
Histopathological examination
Surgically resected tumors were fixed in 10% formalin and embedded in paraffin. For histopathological examinations, sections with the largest tumor areas were stained with hematoxylin-eosin and elastica van Gieson. All lymph nodes were evaluated in the largest sections. From the pathological findings, lung cancers that exhibited nodal, lymphovascular or pleural invasion were defined as invasive lung cancers.
Statistical analysis
We classified subjects according to the following criteria: DWI, age (<70 years of age or not), gender, smoking history (ever or never), histologic type (adenocarcinoma or nonadenocarcinoma), tumor differentiation (well-to moderately differentiated or poorly differentiated) and preoperative CEA level (!5.0 ng/ml or <5.0 ng/ml). This last classification was used to minimize the effects of smoking as much as possible [17] , although the reference value in our hospital is lower than 3.4 ng/ml. From preoperative tumor diameters, subjects were classified into a group with tumors !2.0 cm and a group with tumors <2.0 cm in size. This was based on a report showing that a limited operation can be performed for patients with a preoperative tumor diameter <2.0 cm [1] . By maximum standardized uptake value (SUV max) on FDG-PET/CT, subjects were classified into a group with !5.0 and a group with <5.0, based on a report that SUV max !5.0 is an indicative factor for poor prognosis [18] . We retrospectively assessed the relationships among the above factors. Analyses were done using StatView 5.0 (SAS Table 1 Imaging parameters of diffusion-weighted imaging. Institute, Cary, NC). To compare two factors, a chi-square test or Fisher's exact test was used. To identify independent predictive factors for invasive cancer, multivariate analysis used logistic regression. Differences in continuous variables between two groups were examined using the Mann-Whitney U test. For all analyses, p < 0.05 was considered significant.
Results
Patient characteristics
The subjects were aged 47-86 years (median = 70 years). There were 23 patients (56%) 70 years or older and 18 patients (44%) less than 70 years. By histologic type, adenocarcinoma accounted for the largest percentage of patients, 31 (76%), followed by squamous cell carcinoma with 9 patients (22%) and typical carcinoid in 1 patient (2%). Preoperative CEA levels ranged from 0.57 ng/ml to 16.71 ng/ ml (median = 3.47 ng/ml), with 28 patients (68%) having <5.0 ng/ml and 13 (32%) with !5.0 ng/ml. Preoperative tumor diameters ranged from 0.6 cm to 3.0 cm (median = 2.2 cm), with 27 patients (66%) having !2.0 cm and 14 (34%) with <2.0 cm. For the SUV max levels, while no FDG-PET/CT uptake was observed in some patients, the largest SUV max was 19.35 (median = 4.36). Eighteen patients (44%) had an SUV max !5.0 and 23 had SUV max <5.0 (56%) ( Table 2) . Invasive cancer was observed in 10 patients (24%), lymphatic invasion was observed in 2 patients (5%), vascular invasion in 5 patients (12%), pleural invasion in 7 patients (17%) and lymph node metastasis in 6 patients (15%). Three patients had N2 disease, and three patients had N1 disease identified by surgical resection. There were no lymph nodes measuring >1 cm in diameter.
DWI qualitative evaluation
Upon DWI evaluation, 15 patients (37%), mostly with SUV max !5.0, were DWI-positive, while 26 patients (63%) were DWI-negative. First, we assessed the relationships between DWI and each variable by performing univariate analyses (Table 3) . Thirteen of 27 patients with a preoperative tumor diameter !2.0 cm were DWI-positive ( p = 0.044), and 13 of 18 with SUV max !5.0 were DWI-positive ( p < 0.001). In addition, assessment of the correlation between DWI and SUV max showed a high SUV max value among DWI-positive patients; the mean SUV max value in DWI-positive patients was 10.33 AE 4.93, while that in DWI-negative patients was 3.10 AE 4.21 (Fig. 2) .
Prediction of invasive cancer
Upon univariate analyses of predictive factors for development of invasive cancer (Table 4 ), significant differences were observed for DWI, SUV max and the preoperative CEA level. Invasive cancer was observed in 9 of 15 DWI-positive patients ( p < 0.001), in 9 of 18 patients with SUV max !5.0 ( p = 0.001) and in 6 of 13 patients with a preoperative CEA level !5.0 ng/ml ( p = 0.049). The factors predictive of invasive cancer were then examined by multivariate analysis after excluding the factor of SUV max because of its very strong correlation with DWI. From this analysis, DWI ( p = 0.005) was found to be an independent predictive factor for invasive cancer ( Table 5 ). The sensitivity of DWI for prediction of tumor invasiveness was 90%, its specificity was 81%, its positive predictive value was 60.0% and its negative predictive value was 96%.
Discussion
DWI is used for the diagnoses of hyper-acute cerebral infarctions and other conditions, and its diagnostic value for lesions in the head region is widely recognized [10, 11] . DWI has also been actively used for the whole body [9] [10] [11] after Takahara et al. [15] used diffusion-weighted imaging background suppression (DWIBS) for the first time. Favorable results have been reported by several authors using this imaging system to differentiate between benign and malignant lesions in some organs [12, 13] , and to correlate with the degree of cell differentiation in lung cancer [14] .
DWI chiefly targets the diffusion of water molecules, and indirectly visualizes the diffusion status using phase shifts that are generated when a magnetic field gradient is applied to the area to be examined. Many obstacles limit the diffusion of water molecules within a tissue, including the cell membrane, intracellular cytoskeleton, organelles, matrix fibers and soluble macromolecules [8, [14] [15] [16] . In particular, because water molecules are mainly in extracellular fluids, their diffusion is believed to be more strongly inhibited in tissues with larger cell sizes, or tissues with higher cellular densities, due to the narrowing of extracellular spaces [8, 16] . Accordingly, because tumors with higher cell density, which limits diffusion, can be predicted to have higher cell proliferative potentials, DWI might be expected to improve the prediction of tumor invasiveness. However, many aspects of the usefulness of DWI for malignant tumors remain unclear and require further elucidation.
Lung cancer is one of the highly malignant tumors, with lymph node metastases observed in approximately 20% of patients, even in clinical stage IA [2] . The prognosis for lung cancer is, thus, far from satisfactory. Suzuki et al. [6] studied 389 patients in clinical stage IA NSCLC and reported that lymphatic invasion was observed in 107 patients (28%) and that local or regional lymph node involvement, or intrapulmonary metastasis, was observed in 88 patients (23%). Okada et al. [19] also studied 60 patients with lung adenocarcinoma in clinical stage IA and observed lymphatic invasion in 18 patients (30%), vascular invasion in 13 patients (22%) and lymph node involvement in 8 patients (13%). From these findings, even small lung cancers are sometimes invasive, and selection of limited surgery for such tumors should, therefore, be avoided.
A number of studies have focused upon identifying noninvasive cancer before operations, chiefly in patients with clinical stage IA NSCLC. In recent years, several reports on quantitative diagnoses of tumors have indicated the effectiveness of SUV max values in FDG-PET/CT for identifying highly malignant lung cancer and the potential of SUV max values as prognostic factors for NSCLC [20] [21] [22] . Okada et al. [19] reported that high SUV max values were predictive factors for tumor aggressiveness in patients with lung adenocarcinoma in clinical stage IA. We performed qualitative evaluations to compare tumor signal intensities from DWI with those in the spinal cord. Our findings suggest the possibility for use of DWI for the assessment of tumor invasiveness. Previous quantitative evaluations of MRI diffusion-weighted images were carried out using apparent diffusion coefficients (ADCs) [7, 9, [12] [13] [14] . However, based on our trials, only small differences were found in ADC values, and no significant differences were seen between invasive and non-invasive lung cancers in ADC values (data not shown). Komori et al. [16] also studied 27 patients with malignant tumors and reported no significant difference between a reference organ and malignant tumor ADC values, with overlap of ADC values between malignant tumor and the reference organ. In addition, ADC values vary greatly due, simply, to slight shifts in the region of interest to be measured and they have poor reproducibility. Accordingly, we considered ADC values inappropriate for quantitative evaluations. Based on the above findings, we performed qualitative evaluations using the ratio of tumor signal intensity to spinal signal intensity, which is a strong signal in diffusion-weighted images. This method for qualitative evaluation is advantageous in that it is simple to perform. However, its reproducibility may be limited as it relies on subjective evaluations. More objective evaluations for DWI will be needed in the future. In addition, only 2 of 14 patients with tumor diameter <2 cm, and only 2 of 23 patients with SUV max <5.0 were DWI-positive in this study, so we think that for these cases DWI should be precluded.
In conclusion, the ratio of tumor signal intensity to spinal signal intensity for DWI might be a useful method for predicting tumor invasiveness for clinical stage IA NSCLC and, therefore, further examination will be needed. examination for estimating tumor invasiveness. DWI is still a supplemental examination. Further examination will be needed.
Dr R. Schmid (Berne, Switzerland): The obvious question is, is it related to prognosis? When you do this examination you have identified two groups. I know it was not part of the study, but do you already have a feeling if the examination has any prognostic value?
Dr Kanauchi: Sorry?
Dr Schmid: Patients with invasive tumors in your examination seem to survive less long than the others. Have you identified any correlated parameters for survival?
Dr Kanauchi: We don't examine. Dr Schmid: But would it not be the aim in future? Dr Kanauchi: Yes, as a prognostic factor.
